author-photo

F Oberfrank

Hungarian Academy of Sciences

36

Papers

56

Citations

Citation Trend

Filter By

Papers (26) Sort By

Journal Conference Others

Trimetazidine use in Parkinson's disease: Is it a resolved problem?

2021
Show All
- Source
- Cite
- Save
Citations (0)
Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Age and gender characteristics of patients affected with multiple sclerosis in Hungary between 2004 and 2016

2021 Orvosi Hetilap
Show All
- Source
- Cite
- Save
Citations (0)
Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (3)
The prevalence of psychiatric symptoms before the diagnosis of Parkinson’s disease in a nationwide cohort: A comparison to patients with cerebral infarction

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (3)
Linking individual patient data to estimate incidence and prevalence of Parkinson’s disease by comparing reports of neurological services and pharmacy prescription refills at a nationwide level

2019 Frontiers in Neurology
Show All
- Source
- Cite
- Save
Citations (7)
Health Insurance Cost of Psychotic Disorders In Hungary: A Cost of Illness Study

2017 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Health Insurance Cost of Affective Disorders In Hungary: A Cost of Illness Study

2017 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Health Insurance Cost Of Multiple Sclerosis In Hungary: A Cost Of Illness Study

2016 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)
Health Insurance Cost of Anxiety in Hungary: A Cost of Illness Study.

2014 Value in Health
Show All
- Source
- Cite
- Save
Citations (0)